• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Prospective Changes to HIPAA Rules Would Affect Clinical Labs

Prospective Changes to HIPAA Rules Would Affect Clinical Labs

by Oscelle Boye, MBiomed | Nov 30, 2025 | Essential, HIPAA-nir, Lab Industry Advisor, Legislation-lca, Legislation-lir, Legislation-nir, Operations-lca

With new modifications to HIPAA potentially on the horizon, we hear from experts on HHS' proposal

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
HHS Suddenly Dismantles CLIAC After 33 Years

HHS Suddenly Dismantles CLIAC After 33 Years

by Ron Shinkman | May 29, 2025 | CDC-nir, CLIA-lca, CLIA-nir, CMS-lca, CMS-lir, CMS-nir, Essential, FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor

The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Senators to HHS: Keep Covering At-Home COVID-19 Tests After PHE Ends

Senators to HHS: Keep Covering At-Home COVID-19 Tests After PHE Ends

by Glenn S. Demby | Apr 17, 2023 | News, Open Content

Group of 18 senators says ending Medicare coverage for at-home COVID-19 tests would undo efforts to contain spread of the coronavirus.

FDA to Keep COVID-19 EUA Pipeline Open for Now

FDA to Keep COVID-19 EUA Pipeline Open for Now

by Glenn S. Demby | Mar 29, 2023 | News, Open Content

U.S. Department of Health and Human Services secretary takes action to ensure continued access to COVID-19 EUA products.

No Surprises Act Independent Dispute Resolution Process Resumes

No Surprises Act Independent Dispute Resolution Process Resumes

by Glenn S. Demby | Mar 28, 2023 | News, Open Content

HHS orders arbitrators to go back to resolving payment disputes between providers and payors under the No Surprises Act.

« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2026 G2Intelligence.com